Comments
Loading...

Mineralys Therapeutics

MLYSNASDAQ
Logo brought to you by Benzinga Data
$12.49
00.00%
Pre-Market: Nov 22, 4:00 PM EDT

Mineralys Therapeutics (NASDAQ:MLYS) Stock, Earnings Estimates, EPS, And Revenue

Mineralys Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 11
EPS
$-1.130
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)

Analyze the earnings history of Mineralys Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Mineralys Therapeutics (MLYS) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-11$-1.13$-0.83-36.1 %
Jun 20242024-08-13$-0.83$-0.70-18.6 %
Mar 20242024-05-09$-0.70$-0.67-4.48 %
Dec 20232024-03-21$-0.61$-0.8225.6 %

Mineralys Therapeutics (MLYS) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Mineralys Therapeutics (NASDAQ:MLYS) reporting earnings?

A

Mineralys Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 11, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Mineralys Therapeutics (NASDAQ:MLYS)?

A

Mineralys Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 11, 2024 for Q3 and the Actual EPS was $-1.13, which missed the estimate of $-0.83.

Q

What were Mineralys Therapeutics’s (NASDAQ:MLYS) revenues?

A

Mineralys Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 11, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch